| Code | Description | Claims | Beneficiaries | Total Paid |
| G2067 |
Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) |
189,390 |
55,992 |
$43.44M |
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
989,059 |
105,151 |
$33.34M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
186,326 |
158,191 |
$21.38M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
136,927 |
120,503 |
$15.48M |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
118,700 |
66,747 |
$12.74M |
| 90791 |
Psychiatric diagnostic evaluation |
10,389 |
8,753 |
$9.57M |
| J9271 |
Injection, pembrolizumab, 1 mg |
914 |
740 |
$9.50M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
47,880 |
43,034 |
$8.05M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
31,366 |
29,087 |
$5.15M |
| H0040 |
Assertive community treatment program, per diem |
2,758 |
2,728 |
$5.08M |
| 99215 |
Prolong outpt/office vis |
30,109 |
27,572 |
$4.22M |
| 90834 |
Psychotherapy, 45 minutes with patient |
24,097 |
9,545 |
$4.12M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
27,220 |
25,566 |
$4.12M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
30,347 |
25,094 |
$3.40M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
21,542 |
21,090 |
$3.35M |
| G0378 |
Hospital observation service, per hour |
3,114 |
2,999 |
$3.03M |
| 36415 |
Collection of venous blood by venipuncture |
348,706 |
132,694 |
$2.82M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
44,190 |
20,205 |
$2.64M |
| G0397 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes |
17,730 |
12,844 |
$2.52M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
39,944 |
37,489 |
$2.43M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12,135 |
10,786 |
$2.17M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14,755 |
14,501 |
$2.11M |
| J2426 |
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
987 |
882 |
$1.73M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
491 |
370 |
$1.73M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
9,428 |
6,310 |
$1.55M |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
29,551 |
22,557 |
$1.53M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
7,293 |
7,104 |
$1.52M |
| J0897 |
Injection, denosumab, 1 mg |
1,051 |
994 |
$1.49M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,042 |
6,959 |
$1.31M |
| G2078 |
Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure |
27,274 |
12,341 |
$1.24M |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,940 |
6,672 |
$1.21M |
| H2001 |
Rehabilitation program, per 1/2 day |
8,254 |
1,225 |
$1.19M |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
15,048 |
5,060 |
$1.16M |
| 80053 |
Comprehensive metabolic panel |
80,186 |
59,753 |
$1.12M |
| 20611 |
|
7,137 |
4,285 |
$1.11M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,518 |
1,502 |
$1.07M |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
7,737 |
7,663 |
$1.02M |
| 52000 |
|
1,196 |
1,183 |
$996K |
| 97162 |
|
7,685 |
7,639 |
$977K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,681 |
4,318 |
$976K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
13,218 |
3,145 |
$921K |
| 96415 |
|
3,145 |
2,593 |
$896K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
19,294 |
15,136 |
$859K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
11,217 |
11,180 |
$857K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
38,405 |
17,897 |
$811K |
| 90832 |
Psychotherapy, 30 minutes with patient |
5,718 |
3,397 |
$796K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
5,539 |
5,358 |
$775K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
344 |
272 |
$774K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
52,188 |
46,462 |
$764K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,106 |
6,430 |
$750K |
| 99205 |
Prolong outpt/office vis |
4,119 |
4,064 |
$695K |
| J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj |
179 |
117 |
$680K |
| 87536 |
|
8,636 |
8,530 |
$669K |
| 64615 |
|
1,098 |
1,082 |
$659K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
23,594 |
11,526 |
$622K |
| 93970 |
|
2,350 |
2,322 |
$610K |
| 93458 |
|
361 |
357 |
$594K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,096 |
3,065 |
$591K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
953 |
942 |
$582K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,282 |
2,272 |
$569K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
850 |
847 |
$528K |
| J2350 |
Injection, ocrelizumab, 1 mg |
13 |
13 |
$519K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,014 |
1,725 |
$518K |
| 31237 |
|
355 |
287 |
$510K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
18,059 |
15,936 |
$490K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
28,409 |
26,703 |
$474K |
| 77336 |
|
1,887 |
849 |
$452K |
| 77412 |
|
1,473 |
151 |
$437K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
2,312 |
2,097 |
$437K |
| H0014 |
Alcohol and/or drug services; ambulatory detoxification |
2,352 |
1,488 |
$427K |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
85 |
82 |
$417K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
3,128 |
3,106 |
$406K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
221 |
126 |
$403K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,123 |
3,882 |
$402K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
2,679 |
1,724 |
$401K |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
237 |
228 |
$396K |
| 77386 |
|
1,069 |
88 |
$395K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,481 |
2,790 |
$394K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,571 |
2,545 |
$392K |
| 51798 |
|
2,744 |
2,188 |
$382K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,775 |
3,761 |
$379K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
17,671 |
17,468 |
$371K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,129 |
2,105 |
$366K |
| 31231 |
|
4,229 |
3,983 |
$359K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,419 |
3,407 |
$351K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
139 |
57 |
$344K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,409 |
3,401 |
$342K |
| 80061 |
Lipid panel |
33,650 |
31,609 |
$321K |
| 71250 |
|
4,461 |
4,433 |
$320K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
4,969 |
4,525 |
$320K |
| 76641 |
|
5,124 |
4,860 |
$315K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
459 |
452 |
$314K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
19,351 |
16,712 |
$307K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,679 |
1,654 |
$307K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
1,441 |
1,422 |
$299K |
| 93320 |
|
2,488 |
2,479 |
$298K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
18,001 |
15,901 |
$290K |
| 96367 |
|
3,704 |
2,513 |
$288K |
| 87428 |
|
10,932 |
10,616 |
$286K |
| 10005 |
|
865 |
838 |
$284K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,265 |
1,209 |
$283K |
| 99386 |
|
1,947 |
1,940 |
$274K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
1,293 |
1,189 |
$273K |
| 86361 |
|
9,215 |
8,744 |
$271K |
| 94375 |
|
2,103 |
1,838 |
$270K |
| 70486 |
|
2,925 |
2,894 |
$263K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
8,806 |
6,959 |
$261K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,359 |
2,296 |
$261K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
10,884 |
10,850 |
$256K |
| 93976 |
|
839 |
829 |
$256K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
19,377 |
16,059 |
$255K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,505 |
2,464 |
$255K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14,560 |
11,821 |
$254K |
| 11900 |
|
1,144 |
1,108 |
$252K |
| 99385 |
|
1,651 |
1,643 |
$246K |
| 76536 |
|
3,231 |
3,213 |
$244K |
| 86850 |
|
9,813 |
8,770 |
$242K |
| 86480 |
|
4,165 |
4,110 |
$241K |
| 76830 |
Ultrasound, transvaginal |
3,956 |
3,900 |
$237K |
| 76770 |
|
1,330 |
1,324 |
$235K |
| 51741 |
|
1,402 |
1,375 |
$235K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,372 |
1,253 |
$233K |
| 93880 |
|
1,277 |
1,251 |
$232K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,395 |
1,389 |
$229K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
853 |
850 |
$224K |
| 93975 |
|
668 |
655 |
$214K |
| 96910 |
|
2,275 |
526 |
$214K |
| 70491 |
|
1,346 |
1,340 |
$210K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,891 |
9,724 |
$210K |
| 70543 |
|
678 |
676 |
$208K |
| 77066 |
Tomosynthesis, mammo |
2,431 |
2,422 |
$208K |
| 20610 |
|
738 |
662 |
$204K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,966 |
1,363 |
$200K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
40,898 |
38,001 |
$199K |
| 74183 |
|
744 |
738 |
$195K |
| 46600 |
|
1,060 |
1,053 |
$194K |
| 31575 |
|
1,985 |
1,935 |
$192K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
1,181 |
1,153 |
$191K |
| 80076 |
|
22,678 |
21,234 |
$190K |
| S9485 |
Crisis intervention mental health services, per diem |
163 |
160 |
$188K |
| 77065 |
Tomosynthesis, mammo |
2,942 |
2,774 |
$188K |
| 17110 |
|
810 |
794 |
$187K |
| 86901 |
|
10,026 |
8,778 |
$185K |
| 86900 |
|
10,093 |
8,784 |
$182K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,148 |
1,141 |
$178K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,182 |
1,143 |
$175K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
1,487 |
1,467 |
$169K |
| 71046 |
Radiologic examination, chest; 2 views |
20,174 |
19,420 |
$169K |
| 36000 |
|
9,449 |
9,144 |
$167K |
| 73221 |
|
750 |
725 |
$166K |
| 90677 |
|
1,363 |
1,359 |
$164K |
| 83970 |
|
5,805 |
5,672 |
$164K |
| 76998 |
|
1,056 |
1,034 |
$163K |
| 90686 |
|
9,969 |
9,936 |
$162K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
50,128 |
44,250 |
$155K |
| 86703 |
|
13,134 |
12,936 |
$155K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
231 |
223 |
$148K |
| 88307 |
|
1,056 |
858 |
$145K |
| 93017 |
|
2,416 |
2,401 |
$144K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,230 |
13,000 |
$143K |
| 76642 |
|
2,939 |
2,900 |
$142K |
| 97165 |
|
1,310 |
1,292 |
$142K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
87,222 |
76,711 |
$142K |
| 73564 |
|
6,886 |
5,225 |
$141K |
| 83880 |
|
7,680 |
7,100 |
$141K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,767 |
2,715 |
$140K |
| 97161 |
|
1,365 |
1,355 |
$140K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,685 |
1,677 |
$139K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,647 |
2,246 |
$137K |
| Q5117 |
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg |
142 |
88 |
$135K |
| 90750 |
|
1,134 |
1,110 |
$133K |
| 94060 |
|
901 |
808 |
$130K |
| 12011 |
|
372 |
370 |
$127K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
4,469 |
4,426 |
$121K |
| 93971 |
|
1,911 |
1,831 |
$119K |
| 90836 |
|
1,144 |
820 |
$116K |
| 87507 |
|
786 |
771 |
$114K |
| 99443 |
|
1,514 |
1,471 |
$113K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
882 |
857 |
$113K |
| 12001 |
|
356 |
352 |
$111K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
7,003 |
6,666 |
$110K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
188 |
188 |
$109K |
| 93351 |
|
1,127 |
1,123 |
$109K |
| 88342 |
|
2,132 |
1,924 |
$105K |
| 93325 |
|
2,606 |
2,579 |
$104K |
| 80050 |
General health panel |
4,935 |
4,770 |
$102K |
| 95800 |
|
889 |
885 |
$98K |
| 96417 |
|
2,519 |
1,535 |
$98K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,373 |
3,294 |
$96K |
| 10060 |
|
416 |
407 |
$95K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
4,282 |
4,263 |
$95K |
| 0002A |
|
2,662 |
2,653 |
$95K |
| H0039 |
Assertive community treatment, face-to-face, per 15 minutes |
57 |
57 |
$94K |
| 72197 |
|
365 |
364 |
$93K |
| 90461 |
|
3,545 |
3,535 |
$92K |
| H0033 |
Oral medication administration, direct observation |
2,678 |
318 |
$92K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,191 |
1,075 |
$91K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,273 |
1,264 |
$90K |
| 99051 |
|
8,755 |
8,538 |
$90K |
| 77080 |
|
2,492 |
2,483 |
$89K |
| J0592 |
Injection, buprenorphine hydrochloride, 0.1 mg |
6,206 |
308 |
$89K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
30,073 |
29,829 |
$87K |
| 77049 |
|
284 |
284 |
$87K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
268 |
205 |
$86K |
| 69210 |
|
2,648 |
2,216 |
$85K |
| C1769 |
Guide wire |
2,229 |
1,951 |
$84K |
| 72141 |
|
515 |
512 |
$82K |
| 90715 |
|
4,284 |
4,257 |
$80K |
| 88185 |
|
1,055 |
902 |
$79K |
| 90651 |
|
1,617 |
1,613 |
$79K |
| 19083 |
|
67 |
65 |
$78K |
| 0001A |
|
2,684 |
2,679 |
$78K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,213 |
606 |
$76K |
| 88112 |
|
1,588 |
1,565 |
$76K |
| 95819 |
|
284 |
281 |
$75K |
| 97803 |
|
2,417 |
2,264 |
$75K |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
66 |
63 |
$75K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
9,412 |
9,159 |
$72K |
| G2068 |
Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) |
246 |
101 |
$72K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
703 |
451 |
$71K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
153 |
153 |
$71K |
| 70496 |
|
419 |
419 |
$71K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
148 |
144 |
$71K |
| 87522 |
Neg quan hep c or qual rna |
2,560 |
2,483 |
$71K |
| 87631 |
|
1,686 |
1,653 |
$70K |
| 52356 |
|
46 |
44 |
$70K |
| 85610 |
|
24,203 |
22,849 |
$68K |
| 70480 |
|
605 |
605 |
$67K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,194 |
1,186 |
$66K |
| 84443 |
Thyroid stimulating hormone (TSH) |
20,401 |
19,800 |
$65K |
| 73130 |
|
4,932 |
4,296 |
$64K |
| 99442 |
|
1,127 |
1,097 |
$63K |
| 11102 |
|
169 |
167 |
$63K |
| 99201 |
|
514 |
467 |
$63K |
| 96402 |
|
1,859 |
1,603 |
$63K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
31 |
25 |
$61K |
| 83013 |
|
1,323 |
1,312 |
$60K |
| 88304 |
|
2,672 |
2,521 |
$59K |
| 77334 |
|
172 |
142 |
$59K |
| G0008 |
Administration of influenza virus vaccine |
3,958 |
3,950 |
$58K |
| 93356 |
|
591 |
590 |
$58K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
285 |
224 |
$57K |
| 95886 |
|
814 |
814 |
$56K |
| 90732 |
|
604 |
598 |
$55K |
| 90870 |
|
179 |
68 |
$55K |
| 91200 |
|
1,336 |
1,320 |
$55K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
225 |
145 |
$55K |
| 73030 |
|
4,063 |
3,867 |
$55K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
4,150 |
3,841 |
$54K |
| 88184 |
|
1,001 |
984 |
$54K |
| 84439 |
|
13,111 |
12,758 |
$53K |
| 77300 |
|
162 |
153 |
$52K |
| 92557 |
|
1,393 |
1,312 |
$52K |
| 86803 |
|
15,902 |
15,672 |
$50K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,014 |
1,940 |
$50K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,577 |
1,409 |
$49K |
| 59820 |
|
62 |
61 |
$49K |
| 92551 |
|
1,123 |
1,123 |
$49K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
2,560 |
1,688 |
$49K |
| 94726 |
|
791 |
788 |
$49K |
| 90670 |
|
1,893 |
1,888 |
$48K |
| 73562 |
|
3,313 |
3,172 |
$48K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,150 |
935 |
$46K |
| 74178 |
|
235 |
230 |
$46K |
| C1889 |
Implantable/insertable device, not otherwise classified |
885 |
844 |
$46K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,210 |
1,061 |
$46K |
| 73630 |
|
4,034 |
3,737 |
$45K |
| 86003 |
|
3,399 |
2,155 |
$44K |
| J1944 |
Injection, aripiprazole lauroxil, (aristada), 1 mg |
24 |
24 |
$44K |
| 71271 |
|
574 |
574 |
$42K |
| 87517 |
|
1,228 |
1,197 |
$41K |
| 97016 |
|
2,473 |
1,434 |
$41K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,394 |
1,390 |
$39K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
15,839 |
12,789 |
$39K |
| 92550 |
|
653 |
640 |
$38K |
| 76801 |
|
707 |
636 |
$37K |
| 87652 |
|
1,736 |
1,707 |
$35K |
| 93225 |
|
290 |
285 |
$35K |
| 90837 |
Psychotherapy, 53 minutes with patient |
219 |
127 |
$34K |
| 86769 |
|
1,133 |
1,118 |
$34K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13,038 |
12,177 |
$33K |
| 76818 |
|
694 |
348 |
$33K |
| 82607 |
|
5,705 |
5,639 |
$32K |
| J9045 |
Injection, carboplatin, 50 mg |
1,317 |
908 |
$32K |
| G0009 |
Administration of pneumococcal vaccine |
2,112 |
2,107 |
$32K |
| 92060 |
|
504 |
503 |
$32K |
| J9267 |
Injection, paclitaxel, 1 mg |
1,223 |
669 |
$32K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
6,917 |
6,623 |
$31K |
| 81001 |
|
27,633 |
24,789 |
$31K |
| 90734 |
|
1,560 |
1,553 |
$30K |
| 72100 |
|
1,731 |
1,720 |
$30K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
642 |
633 |
$30K |
| 94729 |
|
813 |
809 |
$30K |
| 82784 |
|
5,323 |
3,346 |
$29K |
| 46607 |
|
49 |
49 |
$29K |
| 82670 |
|
1,979 |
1,918 |
$29K |
| 82728 |
|
5,956 |
5,830 |
$29K |
| 76857 |
|
709 |
698 |
$28K |
| 73610 |
|
2,763 |
2,579 |
$28K |
| J3490 |
Unclassified drugs |
1,731 |
1,571 |
$28K |
| 77062 |
|
689 |
687 |
$28K |
| 84153 |
|
4,003 |
3,743 |
$28K |
| 96401 |
|
604 |
297 |
$27K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
470 |
446 |
$27K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
2,649 |
2,583 |
$26K |
| 95117 |
|
975 |
361 |
$26K |
| 97163 |
|
174 |
174 |
$26K |
| 96920 |
|
118 |
37 |
$26K |
| 93925 |
|
174 |
169 |
$25K |
| 93978 |
|
169 |
168 |
$25K |
| 76937 |
|
195 |
189 |
$25K |
| 73502 |
|
1,827 |
1,789 |
$25K |
| 0004A |
|
684 |
666 |
$25K |
| 85730 |
|
17,311 |
16,516 |
$25K |
| 87902 |
|
115 |
111 |
$25K |
| 86780 |
|
8,938 |
8,822 |
$24K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
147 |
147 |
$24K |
| 85027 |
|
12,246 |
11,831 |
$24K |
| 91320 |
|
318 |
318 |
$24K |
| 88341 |
|
408 |
395 |
$24K |
| 88172 |
|
542 |
479 |
$23K |
| 0124A |
|
628 |
617 |
$23K |
| 87340 |
|
7,762 |
7,353 |
$22K |
| 97116 |
|
785 |
409 |
$22K |
| 77290 |
|
54 |
54 |
$22K |
| 76775 |
|
488 |
483 |
$22K |
| 96376 |
|
2,623 |
2,260 |
$22K |
| 76813 |
|
459 |
435 |
$21K |
| 86706 |
|
5,279 |
5,234 |
$21K |
| 64483 |
|
39 |
38 |
$21K |
| 95911 |
|
255 |
254 |
$21K |
| 92567 |
|
485 |
480 |
$21K |
| 83001 |
|
2,178 |
2,138 |
$21K |
| 73110 |
|
1,997 |
1,830 |
$21K |
| 84403 |
|
1,650 |
1,587 |
$21K |
| 99243 |
|
143 |
143 |
$21K |
| T2022 |
Case management, per month |
185 |
185 |
$20K |
| 90648 |
|
1,750 |
1,746 |
$20K |
| J2704 |
Injection, propofol, 10 mg |
8,945 |
8,008 |
$20K |
| 83655 |
|
1,654 |
1,648 |
$20K |
| 54161 |
|
19 |
19 |
$20K |
| 74174 |
|
90 |
90 |
$19K |
| 88173 |
|
694 |
611 |
$19K |
| 86140 |
|
11,321 |
11,000 |
$19K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
164 |
158 |
$19K |
| 94010 |
|
682 |
602 |
$19K |
| J1631 |
Injection, haloperidol decanoate, per 50 mg |
1,030 |
959 |
$18K |
| 20550 |
|
102 |
102 |
$18K |
| 86160 |
|
3,684 |
1,943 |
$18K |
| H0001 |
Alcohol and/or drug assessment |
100 |
99 |
$17K |
| 82043 |
|
7,606 |
7,313 |
$17K |
| 86704 |
|
4,266 |
4,237 |
$17K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,613 |
1,559 |
$17K |
| C9600 |
Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch |
14 |
12 |
$17K |
| 77061 |
|
466 |
464 |
$17K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
581 |
562 |
$16K |
| 11721 |
|
649 |
508 |
$16K |
| 83002 |
|
1,666 |
1,634 |
$16K |
| 84484 |
|
18,374 |
14,457 |
$16K |
| 92134 |
|
255 |
242 |
$16K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
261 |
255 |
$16K |
| 81003 |
|
11,680 |
11,240 |
$15K |
| 76870 |
|
406 |
403 |
$15K |
| 83735 |
|
10,562 |
8,845 |
$14K |
| 82962 |
|
10,648 |
7,569 |
$14K |
| 90723 |
|
1,360 |
1,358 |
$14K |
| 90661 |
|
604 |
604 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
4,706 |
4,461 |
$14K |
| 84550 |
|
8,201 |
7,684 |
$14K |
| 82977 |
|
7,123 |
6,287 |
$14K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
1,007 |
364 |
$14K |
| 72110 |
|
557 |
552 |
$14K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
231 |
221 |
$14K |
| 83690 |
|
13,204 |
12,365 |
$14K |
| 99381 |
|
131 |
131 |
$14K |
| 82024 |
|
402 |
386 |
$14K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
1,160 |
1,067 |
$14K |
| 19081 |
|
13 |
13 |
$14K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
147 |
62 |
$14K |
| 58100 |
|
39 |
39 |
$13K |
| 90680 |
|
1,135 |
1,132 |
$13K |
| 84146 |
|
1,219 |
1,206 |
$13K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
6,185 |
5,108 |
$13K |
| 95012 |
|
1,214 |
1,202 |
$13K |
| 72170 |
|
915 |
910 |
$13K |
| 95885 |
|
129 |
127 |
$13K |
| 83516 |
|
2,761 |
2,176 |
$13K |
| 51729 |
|
29 |
25 |
$13K |
| 96377 |
|
645 |
494 |
$13K |
| 84100 |
|
8,830 |
7,952 |
$12K |
| 87480 |
|
1,776 |
1,742 |
$12K |
| 96411 |
|
172 |
110 |
$12K |
| 88300 |
|
904 |
765 |
$12K |
| 97802 |
|
177 |
177 |
$12K |
| 87510 |
|
1,771 |
1,737 |
$12K |
| 82378 |
|
1,433 |
1,160 |
$12K |
| C1874 |
Stent, coated/covered, with delivery system |
14 |
13 |
$12K |
| 87660 |
|
1,777 |
1,743 |
$12K |
| 86360 |
|
347 |
341 |
$12K |
| 93922 |
|
295 |
287 |
$12K |
| 99441 |
|
322 |
295 |
$12K |
| A4648 |
Tissue marker, implantable, any type, each |
872 |
828 |
$12K |
| 90674 |
|
622 |
622 |
$12K |
| 59841 |
|
14 |
14 |
$11K |
| 72131 |
|
130 |
130 |
$11K |
| 99417 |
Prolong home eval add 15m |
742 |
730 |
$11K |
| 82550 |
|
6,357 |
6,149 |
$11K |
| 84445 |
|
277 |
273 |
$11K |
| 73080 |
|
696 |
659 |
$11K |
| 86376 |
|
1,450 |
1,442 |
$11K |
| 73560 |
|
1,180 |
1,101 |
$11K |
| 84702 |
|
4,774 |
4,365 |
$11K |
| 76882 |
|
232 |
223 |
$11K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
66 |
66 |
$11K |
| 83615 |
|
5,137 |
4,304 |
$10K |
| 85651 |
|
11,670 |
11,375 |
$10K |
| 84480 |
|
2,745 |
2,703 |
$10K |
| 29580 |
|
56 |
24 |
$10K |
| 86334 |
|
1,227 |
1,121 |
$10K |
| 86431 |
|
4,805 |
4,761 |
$10K |
| 1036F |
|
36,705 |
33,423 |
$10K |
| 29125 |
|
71 |
67 |
$10K |
| 99397 |
|
126 |
76 |
$10K |
| 29540 |
|
64 |
63 |
$10K |
| 86300 |
|
920 |
712 |
$10K |
| 70498 |
|
323 |
323 |
$9K |
| 82533 |
|
1,115 |
987 |
$9K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
70 |
55 |
$9K |
| 86235 |
|
2,784 |
1,638 |
$9K |
| 19281 |
|
13 |
12 |
$9K |
| H2010 |
Comprehensive medication services, per 15 minutes |
153 |
139 |
$9K |
| 0003A |
|
232 |
230 |
$9K |
| 90633 |
|
1,195 |
1,194 |
$9K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
831 |
815 |
$9K |
| 93308 |
|
55 |
54 |
$9K |
| 81025 |
|
3,873 |
3,626 |
$9K |
| 92015 |
Determination of refractive state |
655 |
655 |
$9K |
| 92610 |
|
103 |
98 |
$9K |
| H0050 |
Alcohol and/or drug services, brief intervention, per 15 minutes |
177 |
160 |
$9K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
20 |
20 |
$8K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,079 |
2,978 |
$8K |
| 72050 |
|
277 |
275 |
$8K |
| 74018 |
|
732 |
709 |
$8K |
| 83520 |
|
1,144 |
1,111 |
$8K |
| 90739 |
|
115 |
114 |
$8K |
| 86147 |
|
447 |
442 |
$8K |
| 90694 |
|
629 |
628 |
$8K |
| 86800 |
|
1,215 |
1,052 |
$7K |
| 82785 |
|
1,243 |
1,216 |
$7K |
| 72040 |
|
404 |
403 |
$7K |
| 95249 |
|
217 |
213 |
$7K |
| 90480 |
|
322 |
322 |
$7K |
| 64616 |
|
12 |
12 |
$7K |
| 86592 |
|
4,835 |
4,764 |
$7K |
| 82172 |
|
942 |
932 |
$7K |
| 81374 |
|
109 |
109 |
$7K |
| 86141 |
|
1,388 |
1,370 |
$7K |
| 87040 |
|
4,056 |
2,372 |
$7K |
| 82105 |
|
2,096 |
2,011 |
$7K |
| 90662 |
|
537 |
536 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
175 |
173 |
$7K |
| 0071A |
|
166 |
164 |
$7K |
| 90620 |
|
561 |
561 |
$7K |
| 51797 |
|
29 |
25 |
$6K |
| 36416 |
|
469 |
448 |
$6K |
| 92558 |
|
195 |
195 |
$6K |
| 87070 |
|
2,279 |
2,178 |
$6K |
| 73590 |
|
847 |
802 |
$6K |
| 84156 |
|
4,003 |
3,672 |
$6K |
| 0072A |
|
157 |
154 |
$6K |
| 87186 |
|
3,057 |
2,777 |
$6K |
| 83010 |
|
1,131 |
1,117 |
$6K |
| 76942 |
|
53 |
53 |
$6K |
| 96368 |
|
387 |
327 |
$6K |
| 73523 |
|
262 |
257 |
$6K |
| 82570 |
|
2,829 |
2,668 |
$6K |
| 95912 |
|
50 |
50 |
$6K |
| 86200 |
|
1,053 |
1,045 |
$6K |
| 83883 |
|
1,131 |
1,071 |
$6K |
| 99493 |
|
82 |
64 |
$6K |
| 90882 |
|
322 |
266 |
$6K |
| 73140 |
|
581 |
551 |
$6K |
| 82652 |
|
330 |
328 |
$5K |
| H0038 |
Self-help/peer services, per 15 minutes |
222 |
206 |
$5K |
| 84165 |
|
1,486 |
1,377 |
$5K |
| 36430 |
|
15 |
13 |
$5K |
| 51600 |
|
16 |
12 |
$5K |
| 99383 |
|
37 |
37 |
$5K |
| 90707 |
|
325 |
323 |
$5K |
| 93226 |
|
74 |
73 |
$5K |
| 57454 |
|
12 |
12 |
$5K |
| 88313 |
|
363 |
306 |
$5K |
| 51702 |
|
27 |
26 |
$4K |
| 99401 |
|
53 |
52 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,950 |
4,765 |
$4K |
| 82627 |
|
320 |
317 |
$4K |
| 92504 |
|
513 |
452 |
$4K |
| 86039 |
|
1,394 |
1,381 |
$4K |
| 46601 |
|
13 |
13 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
232 |
229 |
$4K |
| 86225 |
|
1,466 |
1,428 |
$4K |
| C1753 |
Catheter, intravascular ultrasound |
25 |
25 |
$3K |
| 82565 |
|
1,477 |
1,434 |
$3K |
| 86038 |
|
1,163 |
1,151 |
$3K |
| 88177 |
|
73 |
66 |
$3K |
| 84432 |
|
295 |
289 |
$3K |
| 85378 |
|
3,191 |
3,083 |
$3K |
| 90656 |
|
346 |
346 |
$3K |
| 84481 |
|
769 |
758 |
$3K |
| 82746 |
|
642 |
633 |
$3K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
1,991 |
1,984 |
$3K |
| 86593 |
|
2,599 |
2,548 |
$3K |
| 80164 |
|
598 |
567 |
$3K |
| 92526 |
|
21 |
12 |
$3K |
| 71100 |
|
284 |
276 |
$3K |
| 73700 |
|
16 |
14 |
$3K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
67 |
66 |
$3K |
| G0010 |
Administration of hepatitis b vaccine |
182 |
176 |
$3K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,568 |
1,143 |
$3K |
| 86762 |
|
422 |
419 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
90 |
82 |
$3K |
| 74455 |
|
24 |
24 |
$3K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
148 |
119 |
$3K |
| 95250 |
|
16 |
15 |
$3K |
| 73090 |
|
482 |
455 |
$3K |
| 86765 |
|
433 |
428 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,100 |
962 |
$2K |
| 99358 |
Prolong nursin fac eval 15m |
27 |
27 |
$2K |
| 88311 |
|
382 |
355 |
$2K |
| 83521 |
|
688 |
360 |
$2K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
14 |
13 |
$2K |
| 77417 |
|
51 |
26 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,948 |
7,455 |
$2K |
| 92020 |
|
43 |
43 |
$2K |
| 82247 |
|
1,109 |
1,086 |
$2K |
| 86682 |
|
1,014 |
870 |
$2K |
| 90746 |
|
66 |
61 |
$2K |
| 90716 |
|
197 |
197 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
218 |
218 |
$2K |
| 86618 |
|
261 |
253 |
$2K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
37 |
37 |
$2K |
| 83921 |
|
259 |
257 |
$2K |
| 97010 |
|
148 |
70 |
$2K |
| 86256 |
|
218 |
113 |
$2K |
| 93926 |
|
25 |
25 |
$2K |
| 82248 |
|
1,285 |
1,219 |
$2K |
| 84460 |
|
1,050 |
1,038 |
$2K |
| 93270 |
|
29 |
29 |
$2K |
| 82947 |
|
4,656 |
3,725 |
$2K |
| 87075 |
|
654 |
622 |
$2K |
| 72114 |
|
65 |
65 |
$2K |
| 90710 |
|
266 |
266 |
$2K |
| 87205 |
|
1,671 |
1,569 |
$2K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,070 |
807 |
$2K |
| 81479 |
Unlisted molecular pathology procedure |
35 |
19 |
$2K |
| 99384 |
|
12 |
12 |
$2K |
| 83090 |
|
196 |
193 |
$2K |
| 90700 |
|
182 |
182 |
$2K |
| 86335 |
|
78 |
62 |
$2K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
938 |
628 |
$2K |
| 83550 |
|
600 |
596 |
$2K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
661 |
657 |
$1K |
| 83695 |
|
189 |
188 |
$1K |
| 93280 |
|
82 |
66 |
$1K |
| S0028 |
Injection, famotidine, 20 mg |
3,594 |
3,108 |
$1K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,396 |
2,676 |
$1K |
| 84681 |
|
151 |
148 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,717 |
8,453 |
$1K |
| 90653 |
|
158 |
158 |
$1K |
| 90696 |
|
184 |
184 |
$1K |
| 73600 |
|
163 |
153 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
527 |
517 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13,662 |
12,376 |
$1K |
| 81002 |
|
1,160 |
1,110 |
$1K |
| 51784 |
|
31 |
25 |
$1K |
| 82107 |
|
37 |
37 |
$1K |
| 99496 |
|
24 |
24 |
$1K |
| 83930 |
|
706 |
699 |
$1K |
| 73070 |
|
338 |
322 |
$1K |
| 84703 |
|
3,549 |
3,434 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,659 |
2,982 |
$1K |
| 74160 |
|
12 |
12 |
$1K |
| 96523 |
|
42 |
41 |
$1K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
1,977 |
1,941 |
$1K |
| A9581 |
Injection, gadoxetate disodium, 1 ml |
15 |
15 |
$1K |
| 73620 |
|
255 |
235 |
$1K |
| 99153 |
Mod sedat endo service >5yrs |
620 |
595 |
$1K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,935 |
1,958 |
$1K |
| 97804 |
|
39 |
38 |
$1K |
| 87430 |
|
934 |
922 |
$1K |
| 84300 |
|
526 |
512 |
$1K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
25 |
25 |
$980.51 |
| 80178 |
|
269 |
252 |
$966.91 |
| 99152 |
|
771 |
742 |
$962.82 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
29 |
28 |
$950.07 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
7,035 |
6,757 |
$945.29 |
| 84145 |
|
228 |
225 |
$928.28 |
| 92133 |
|
12 |
12 |
$922.98 |
| 84270 |
|
58 |
58 |
$911.62 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
220 |
207 |
$899.29 |
| 90698 |
|
146 |
146 |
$876.79 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
305 |
293 |
$874.21 |
| A9699 |
Radiopharmaceutical, therapeutic, not otherwise classified |
37 |
36 |
$862.56 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,149 |
934 |
$861.44 |
| 84425 |
|
132 |
130 |
$830.74 |
| J1815 |
Injection, insulin, per 5 units |
829 |
515 |
$803.88 |
| 82088 |
|
27 |
24 |
$800.17 |
| 90714 |
|
40 |
40 |
$796.94 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,010 |
2,737 |
$786.15 |
| 84402 |
|
50 |
50 |
$785.67 |
| 86606 |
|
195 |
194 |
$781.13 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,402 |
10,215 |
$769.89 |
| 83993 |
|
143 |
141 |
$733.19 |
| 86304 |
|
77 |
71 |
$723.99 |
| 83540 |
|
296 |
292 |
$719.98 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
211 |
205 |
$700.00 |
| 85612 |
|
200 |
198 |
$673.90 |
| 84436 |
|
248 |
248 |
$648.68 |
| 86735 |
|
156 |
153 |
$643.77 |
| C1781 |
Mesh (implantable) |
26 |
25 |
$619.34 |
| 80346 |
|
25 |
25 |
$617.69 |
| S0109 |
Methadone, oral, 5 mg |
59 |
39 |
$614.95 |
| J9171 |
Injection, docetaxel, 1 mg |
13 |
12 |
$607.76 |
| 70220 |
|
32 |
32 |
$593.11 |
| 93793 |
|
95 |
39 |
$590.32 |
| C1819 |
Surgical tissue localization and excision device (implantable) |
43 |
41 |
$570.24 |
| 72070 |
|
61 |
61 |
$536.09 |
| 0042T |
|
12 |
12 |
$522.87 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,448 |
2,024 |
$503.45 |
| 88360 |
|
16 |
12 |
$503.28 |
| 90744 |
|
86 |
86 |
$499.80 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
516 |
473 |
$493.06 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
13 |
13 |
$483.04 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
864 |
602 |
$462.27 |
| 87338 |
|
97 |
97 |
$448.92 |
| 86580 |
|
29 |
27 |
$447.29 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
106 |
91 |
$447.10 |
| 74430 |
|
13 |
13 |
$439.02 |
| 4004F |
|
8,453 |
7,777 |
$436.63 |
| 80069 |
|
68 |
67 |
$385.39 |
| 73503 |
|
17 |
16 |
$380.03 |
| 87109 |
|
94 |
94 |
$375.09 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
12 |
12 |
$372.43 |
| 86709 |
|
120 |
118 |
$367.21 |
| 83498 |
|
39 |
38 |
$351.40 |
| 86705 |
|
132 |
132 |
$346.88 |
| 73060 |
|
100 |
96 |
$340.20 |
| 82390 |
|
94 |
94 |
$336.98 |
| 90681 |
|
51 |
51 |
$323.44 |
| 84144 |
|
24 |
24 |
$309.88 |
| 82040 |
|
575 |
558 |
$306.71 |
| 82157 |
|
31 |
30 |
$292.80 |
| 91308 |
|
86 |
84 |
$275.28 |
| 36591 |
|
13 |
13 |
$271.49 |
| J3480 |
Injection, potassium chloride, per 2 meq |
334 |
179 |
$271.46 |
| 82330 |
|
95 |
84 |
$259.28 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,950 |
1,777 |
$255.43 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
64 |
60 |
$251.57 |
| C1758 |
Catheter, ureteral |
100 |
95 |
$241.24 |
| 86787 |
|
54 |
53 |
$230.73 |
| 86316 |
|
28 |
25 |
$226.85 |
| 87116 |
|
43 |
41 |
$226.80 |
| 82010 |
|
212 |
194 |
$223.85 |
| 84154 |
|
31 |
31 |
$218.84 |
| G2077 |
Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and patient-identified goals, and other relevant physical, nutrition and psychiatric treatment needs and goals; may be informed by administration of a standardized, evidence-based assessment, or the need and interest for harm reduction interventions and recovery support services (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code |
96 |
79 |
$212.64 |
| 84105 |
|
73 |
70 |
$209.61 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,107 |
1,070 |
$206.27 |
| 73522 |
|
13 |
13 |
$200.63 |
| 87101 |
|
67 |
66 |
$199.85 |
| 88302 |
|
13 |
12 |
$189.48 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,483 |
3,364 |
$186.77 |
| 83605 |
|
225 |
195 |
$186.18 |
| 87077 |
|
76 |
67 |
$185.86 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
866 |
848 |
$178.53 |
| 86301 |
|
40 |
36 |
$177.45 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
255 |
128 |
$173.34 |
| 86328 |
|
18 |
17 |
$172.01 |
| 81381 |
|
13 |
13 |
$169.90 |
| 77072 |
|
14 |
14 |
$163.96 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
28 |
28 |
$156.39 |
| J2060 |
Injection, lorazepam, 2 mg |
1,281 |
1,170 |
$154.84 |
| 84133 |
|
75 |
70 |
$144.41 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
342 |
334 |
$139.74 |
| 82175 |
|
62 |
37 |
$132.79 |
| 82397 |
|
14 |
14 |
$125.67 |
| 82436 |
|
60 |
55 |
$121.21 |
| 86701 |
|
12 |
12 |
$118.90 |
| 85007 |
|
155 |
139 |
$116.29 |
| 86708 |
|
14 |
14 |
$111.10 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
2,325 |
1,859 |
$96.93 |
| 73100 |
|
14 |
12 |
$95.90 |
| 82610 |
|
15 |
15 |
$88.46 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
125 |
123 |
$85.76 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,476 |
3,140 |
$82.11 |
| 84132 |
|
80 |
72 |
$81.94 |
| 86162 |
|
15 |
15 |
$81.32 |
| 82955 |
|
13 |
13 |
$79.70 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
2,207 |
1,827 |
$77.10 |
| 74019 |
|
14 |
14 |
$73.04 |
| OP250 |
|
66 |
41 |
$69.60 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,057 |
1,691 |
$68.75 |
| 85045 |
|
45 |
44 |
$67.59 |
| 73552 |
|
13 |
12 |
$62.63 |
| 82365 |
|
37 |
33 |
$62.19 |
| 85384 |
|
78 |
70 |
$59.60 |
| 90611 |
|
109 |
109 |
$55.99 |
| 86255 |
|
13 |
13 |
$52.00 |
| 91312 |
|
513 |
510 |
$51.10 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
67 |
62 |
$48.00 |
| 83935 |
|
14 |
14 |
$47.50 |
| J1940 |
Injection, furosemide, up to 20 mg |
164 |
100 |
$43.63 |
| 80177 |
|
15 |
15 |
$42.73 |
| 82140 |
|
15 |
13 |
$37.12 |
| 82150 |
|
14 |
12 |
$30.18 |
| 91307 |
|
314 |
279 |
$28.74 |
| 85347 |
|
86 |
70 |
$24.34 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
43 |
28 |
$22.69 |
| 84520 |
|
14 |
14 |
$22.39 |
| 84075 |
|
76 |
74 |
$20.61 |
| J7050 |
Infusion, normal saline solution, 250 cc |
236 |
165 |
$19.83 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
2,551 |
1,896 |
$17.84 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
7,972 |
7,252 |
$17.01 |
| 82270 |
|
55 |
54 |
$15.93 |
| 91300 |
|
4,140 |
3,753 |
$14.15 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
56 |
53 |
$13.14 |
| 84155 |
|
54 |
53 |
$12.91 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
124 |
123 |
$12.80 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
93 |
92 |
$10.36 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
14 |
14 |
$8.89 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
163 |
157 |
$7.60 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
557 |
502 |
$7.48 |
| 84450 |
|
56 |
55 |
$6.78 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
68 |
66 |
$6.17 |
| J1598 |
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg |
54 |
53 |
$5.82 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
103 |
102 |
$5.18 |
| J3411 |
Injection, thiamine hcl, 100 mg |
33 |
25 |
$3.53 |
| 87449 |
|
15 |
15 |
$3.30 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
39 |
38 |
$0.46 |
| G9687 |
Hospice services provided to patient any time during the measurement period |
92 |
86 |
$0.23 |
| 3077F |
|
247 |
228 |
$0.21 |
| 3079F |
|
308 |
288 |
$0.18 |
| 3078F |
|
328 |
300 |
$0.18 |
| 3074F |
|
298 |
281 |
$0.13 |
| 3080F |
|
141 |
132 |
$0.13 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
15 |
15 |
$0.13 |
| 3075F |
|
212 |
200 |
$0.12 |
| 1123F |
|
126 |
103 |
$0.01 |
| 83050 |
|
84 |
76 |
$0.00 |
| G2074 |
Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) |
39 |
22 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
71 |
66 |
$0.00 |
| 3044F |
|
13 |
13 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
13 |
12 |
$0.00 |
| 99080 |
|
3,041 |
680 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
28 |
28 |
$0.00 |
| 99499 |
|
1,527 |
836 |
$0.00 |
| J2210 |
Injection, methylergonovine maleate, up to 0.2 mg |
29 |
29 |
$0.00 |
| 82375 |
|
84 |
76 |
$0.00 |